A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy

A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy

Gary T Ferguson,1 Edward M Kerwin,2 Tara Rheault,3 Thomas Bengtsson,4 Kathleen Rickard3 1Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA; 2Altitude Clinical Consulting, Medford, OR, USA; 3Verona Pharma, Plc, Raleigh, NC, USA; 4Stat Mind AB, Lund, SwedenCorrespondence: T...

Full description

Bibliographic Details
Main Authors: Ferguson GT, Kerwin EM, Rheault T, Bengtsson T, Rickard K
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:International Journal of COPD
Subjects:
dual pde3 & 4 inhibitor
phosphodiesterase
copd
tiotropium
bronchodilation
Online Access:https://www.dovepress.com/a-dose-ranging-study-of-the-novel-inhaled-dual-pde-3-and-4-inhibitor-e-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/a-dose-ranging-study-of-the-novel-inhaled-dual-pde-3-and-4-inhibitor-e-peer-reviewed-fulltext-article-COPD

Similar Items